Hana Feki

Loïc Chadoutaud, Alice Blondel, Hana Feki et al.

Computational pathology relies on effective representation learning to support cancer research and precision medicine. Although self-supervised learning has driven major progress at the patch and whole-slide image levels, representation learning at the single-cell level remains comparatively underexplored, despite its importance for characterizing cell types and cellular phenotypes. We introduce LEMON (Learning Embeddings from Morphology Of Nuclei), a self-supervised foundation model for scalable single-cell image representation learning. Trained on millions of cell images from diverse tissues and cancer types, LEMON learns robust and versatile morphological representations that support large-scale single-cell analyses in pathology. We evaluate LEMON on five benchmark datasets across a range of prediction tasks and show that it provides strong performance, highlighting its potential as a new paradigm for cell-level computational pathology. Model weights are available at https://huggingface.co/aliceblondel/LEMON.

Hana Feki, Alice Blondel, Thomas Walter

Accurate mitotic figure classification is crucial in computational pathology, as mitotic activity informs cancer grading and patient prognosis. Distinguishing atypical mitotic figures (AMFs), which indicate higher tumor aggressiveness, from normal mitotic figures (NMFs) remains challenging due to subtle morphological differences and high intra-class variability. This task is further complicated by domain shifts, including variations in organ, tissue type, and scanner, as well as limited annotations and severe class imbalance. To address these challenges in Track 2 of the MIDOG 2025 Challenge, we propose a solution based on the lightweight ConvNeXt architecture, trained on all available datasets (AMi-Br, AtNorM-Br, AtNorM-MD, and OMG-Octo) to maximize domain coverage. Robustness is enhanced through a histopathology-specific augmentation pipeline, including elastic and stain-specific transformations, and balanced sampling to mitigate class imbalance. A grouped 5-fold cross-validation strategy ensures reliable evaluation. On the preliminary leaderboard, our model achieved a balanced accuracy of 0.8961, ranking among the top entries. These results highlight that broad domain exposure combined with targeted augmentation strategies is key to building accurate and generalizable mitotic figure classifiers.

Raphaël Bourgade, Guillaume Balezo, Hana Feki et al.

Mitotic figures represent a key histoprognostic feature in tumor pathology, providing crucial insights into tumor aggressiveness and proliferation. However, their identification remains challenging, subject to significant inter-observer variability, even among experienced pathologists. To address this issue, the MItosis DOmain Generalization (MIDOG) 2025 challenge marks the third edition of an international competition aiming to develop robust mitosis detection algorithms. In this paper, we present a mitotic figure detection approach based on the state-of-the-art YOLOv12 object detection architecture. Our method achieved an F1-score of 0.801 on the preliminary test set (hotspots only) and ranked second on the final test leaderboard with an F1-score of 0.7216 across complex and heterogeneous whole-slide regions, without relying on external data.

Guillaume Balezo, Hana Feki, Raphaël Bourgade et al.

Atypical mitotic figures (AMFs) represent abnormal cell division associated with poor prognosis. Yet their detection remains difficult due to low prevalence, subtle morphology, and inter-observer variability. The MIDOG 2025 challenge introduces a benchmark for AMF classification across multiple domains. In this work, we fine-tuned the recently published DINOv3-H+ vision transformer, pretrained on natural images, using low-rank adaptation (LoRA), training only ~1.3M parameters in combination with extensive augmentation and a domain-weighted Focal Loss to handle domain heterogeneity. Despite the domain gap, our fine-tuned DINOv3 transfers effectively to histopathology, reaching first place on the final test set. These results highlight the advantages of DINOv3 pretraining and underline the efficiency and robustness of our fine-tuning strategy, yielding state-of-the-art results for the atypical mitosis classification challenge in MIDOG 2025.